Finally, we aimed to explore the expression, function, and clinical significance of CKAP2L in ESCC, and further reveal the underlying regulatory and drug-resistant mechanism of CKAP2L in promoting ESCC progression. Here, CKAP2L is linked to esophageal squamous cell carcinoma.